TY - JOUR
T1 - Comparison of visual assessment of coronary stenosis with independent quantitative coronary angiography
T2 - Findings from the Prospective Multicenter Imaging Study for Evaluation of Chest Pain (PROMISE) trial
AU - Shah, Rohan
AU - Yow, Eric
AU - Jones, William Schuyler
AU - Kohl, Louis P.
AU - Kosinski, Andrzej S.
AU - Hoffmann, Udo
AU - Lee, Kerry L.
AU - Fordyce, Christopher B.
AU - Mark, Daniel B.
AU - Lowe, Alicia
AU - Douglas, Pamela S.
AU - Patel, Manesh R.
N1 - Funding Information:
Dr Hoffmann reported receiving grant support from Siemens Healthcare and HeartFlow. Dr Mark reported receiving personal fees from Medtronic, CardioDx, and St Jude Medical and grant support from Eli Lilly, Bristol-Myers Squibb, Gilead Sciences, AGA Medical, Merck, Oxygen Biotherapeutics, and AstraZeneca. Dr Douglas reported receiving grant support from HeartFlow and serves on a data and safety monitoring board for General Electric Healthcare. Dr Patel reported receiving grants from Heart Flow Technologies, Jansen, Johnson & Johnson, Astra Zeneca, and AHRQ, and has served on advisory boards for Astra Zeneca, Bayer, and Otsuka. No other potential conflict of interest relevant to this article was reported.
Publisher Copyright:
© 2016
PY - 2017/2/1
Y1 - 2017/2/1
N2 - The outcomes in patients by visual assessment and quantitative coronary angiography (QCA) for obstructive coronary artery disease (CAD) are not known. Our objectives were to compare visual and QCA estimates of obstructive CAD and to assess their relationship to outcomes in stable patients with symptoms of CAD. Methods The PROMISE trial randomized 10,003 patients with CAD symptoms to anatomical or functional testing. Site reports of invasive angiography detailing visual stenosis and independent, blinded QCA were performed for obstructive CAD (≥50% stenosis). Disagreement between methods was determined and compared with outcomes (death, myocardial infarction, unstable angina hospitalization, or major procedural complications). Results Of 929 patients (9.3% of PROMISE cohort) with angiograms assessed by sites and QCA, 593 (64%) had obstructive CAD per site reports, whereas 428 (46%) had stenosis ≥50% per QCA. Results differed in 177 patients (disagreement rate 19.1%, κ = 0.63), of whom 171 had CAD per sites but not per QCA. One-year unadjusted Kaplan-Meier event rates were highest (5.1%) when QCA and visual assessment agreed for CAD, lowest (0.9%) when the 2 agreed for no obstructive CAD, and intermediate (3.1%) for patients who had CAD per visual assessment but not per QCA. Conclusions Visual estimation of angiograms results in more frequent diagnosis of obstructive CAD as compared with QCA. Concordance of results for presence or absence of obstructive CAD was associated with high and low event rates, respectively. Disagreement was associated with intermediate event rates, suggesting that cardiologists integrated clinical information into routine visual assessment of angiograms.
AB - The outcomes in patients by visual assessment and quantitative coronary angiography (QCA) for obstructive coronary artery disease (CAD) are not known. Our objectives were to compare visual and QCA estimates of obstructive CAD and to assess their relationship to outcomes in stable patients with symptoms of CAD. Methods The PROMISE trial randomized 10,003 patients with CAD symptoms to anatomical or functional testing. Site reports of invasive angiography detailing visual stenosis and independent, blinded QCA were performed for obstructive CAD (≥50% stenosis). Disagreement between methods was determined and compared with outcomes (death, myocardial infarction, unstable angina hospitalization, or major procedural complications). Results Of 929 patients (9.3% of PROMISE cohort) with angiograms assessed by sites and QCA, 593 (64%) had obstructive CAD per site reports, whereas 428 (46%) had stenosis ≥50% per QCA. Results differed in 177 patients (disagreement rate 19.1%, κ = 0.63), of whom 171 had CAD per sites but not per QCA. One-year unadjusted Kaplan-Meier event rates were highest (5.1%) when QCA and visual assessment agreed for CAD, lowest (0.9%) when the 2 agreed for no obstructive CAD, and intermediate (3.1%) for patients who had CAD per visual assessment but not per QCA. Conclusions Visual estimation of angiograms results in more frequent diagnosis of obstructive CAD as compared with QCA. Concordance of results for presence or absence of obstructive CAD was associated with high and low event rates, respectively. Disagreement was associated with intermediate event rates, suggesting that cardiologists integrated clinical information into routine visual assessment of angiograms.
UR - http://www.scopus.com/inward/record.url?scp=84995735522&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84995735522&partnerID=8YFLogxK
U2 - 10.1016/j.ahj.2016.10.014
DO - 10.1016/j.ahj.2016.10.014
M3 - Article
C2 - 27892881
AN - SCOPUS:84995735522
SN - 0002-8703
VL - 184
SP - 1
EP - 9
JO - American Heart Journal
JF - American Heart Journal
ER -